Mexican Public Opinion on Vapeador Ban by Mid-2025?
Support the ban • 25%
Oppose the ban • 25%
Prefer regulation • 25%
Indifferent • 25%
Public opinion surveys or polls conducted by reputable organizations
Mexico's Cámara de Diputados Approves Ban on Vapeadores and Fentanilo with 410 Votes, 24 Against, No Abstentions on December 3, 2024
Dec 3, 2024, 08:59 PM
On December 3, 2024, the Cámara de Diputados in Mexico approved a constitutional reform to prohibit the production, distribution, and commercialization of vapeadores (vape devices) and cigarrillos electrónicos (electronic cigarettes). The reform received overwhelming support, passing with 410 votes in favor, 24 against, and no abstentions. This legislative action aims to protect public health and combat the illicit use of substances, including fentanilo (fentanyl). The reform will now proceed to the presidential sanction after being approved in its final debate. During the discussions, several legislators expressed concerns that the prohibition could lead to an increase in illegal markets and did not effectively address the consumption issue. Notably, some opposition members criticized the ban, arguing for regulation instead of prohibition, highlighting that such measures may not yield the desired results in curbing usage.
View original story
Strongly oppose • 25%
Moderately support • 25%
Strongly support • 25%
Moderately oppose • 25%
Under 40% • 25%
40% to 60% • 25%
Over 80% • 25%
61% to 80% • 25%
More favorable • 25%
Other sentiment shift • 25%
Unchanged • 25%
Less favorable • 25%
Majority support • 25%
Indifference • 25%
Majority oppose • 25%
Mixed opinions • 25%
Majority oppose • 25%
Majority support • 25%
Unclear/Other • 25%
Evenly split • 25%
Major support • 25%
Major opposition • 25%
Indifferent • 25%
Mixed opinions • 25%
No major campaigns launched • 25%
Federal government initiative • 25%
State government initiative • 25%
Non-profit organization initiative • 25%
Supportive • 25%
Indifferent • 25%
Mixed • 25%
Opposed • 25%
Industry group • 25%
Other • 25%
Individual lawsuit • 25%
Health advocacy group • 25%